Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nasopharyngeal Carcinoma × MK 2206 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Gallbladder Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thymoma 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Recurrent Squamous Cell Carcinoma of the Nasopharynx 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Hemangiosarcoma 1 Glioma 1 Fallopian Tube Neoplasms 1 Endometrial Adenocarcinoma 1

Interventions

Cisplatin 47 Gemcitabine 24 toripalimab 17 Radiotherapy, Intensity-Modulated 17 Capecitabine 16 Fluorouracil 15 Docetaxel 14 camrelizumab 13 nimotuzumab 12 apatinib 9 Drug Therapy 9 Radiotherapy 8 sintilimab 7 Nivolumab 7 tislelizumab 6 spartalizumab 6 endostar protein 6 Specimen Handling 6 Magnetic Resonance Spectroscopy 6 Bevacizumab 6 pembrolizumab 5 nedaplatin 5 Radiation 5 Immune Checkpoint Inhibitors 5 Endostatins 5 Chemoradiotherapy 5 Cetuximab 5 S 1 (combination) 4 Paclitaxel 4 Carboplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01370070 2017-01-13

MC1079

Chinese University of Hong Kong

Phase 2 Completed

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡